NCT00908674 - Androcur Effects on Quality of Life | Biotech Hunter

Enrollment

245

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Prostate Cancer

Interventions

DRUG

Cyproterone acetate (Androcur)

"The study drug will be administered either as monotherapy or in combination with other interventions (surgical castration or LHRH analogue treatment).~Daily dosage as monotherapy: 200-300 mg cyproterone acetate. Daily dosage following surgical castration: 100-200 mg cyproterone acetate. Daily dosage in combination with an LHRH-analogue: 100-200 mg cyproterone acetate.~Administration period: 12 months."

Trial Locations (1)

Unknown

Many Locations